Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.603
Delayed Data
As of Apr 28
 +0.0015 / +0.25%
Today’s Change
0.50
Today|||52-Week Range
1.15
+11.67%
Year-to-Date

Today’s Trading

Previous close0.60
Today’s open0.60
Day’s range0.60 - 0.61
Volume175,303
Average volume (3 months)454,590
Market cap$66.5M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-44.44%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)-86.78%
P/E ratioNM
Price/Sales14.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SYNSynthetic Biologics ...-0.02-3.39%
CAPRCapricor Therapeutic...-0.04-1.27%
EIGREiger BioPharmaceuti...+0.25+3.27%
CXRXConcordia Internatio...0.000.00%
Data as of 4:00pm ET, 04/28/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$2.5M
Annual profit (last year)-$26.9M
Net profit margin-1,069.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael P. Bailey
CFO &
Principal Accounting Officer
Keith S. Ehrlich
Corporate headquarters
Cambridge, Massachusetts

Forecasts